Lilly Buys Vaccine Makers
Eli Lilly acquires three vaccine makers for nearly $4 billion, expanding its vaccine portfolio. The move marks a significant push into the vaccine market for the drugmaker.
The drugmaker announced it will buy three privately held vaccine makers in deals worth almost $4 billion combined.